APO Research
Talk to an analyst

APO RESEARCH · REPORT

Total Artificial Heart

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

Selected research

Market Structure

Global Total Artificial Heart Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026187 pages

Choose your research edition.

Industry ResearchTotal Artificial Heart Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Total Artificial Heart Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Total Artificial Heart Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Total Artificial Heart Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Total Artificial Heart Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.

This report provides an overview of the global Total Artificial Heart market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Total Artificial Heart and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Total Artificial Heart sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Total Artificial Heart market size, projected growth trends, production technologies, key applications, and end-use industries.

Total Artificial Heart Segment by Company

BiVACOR

SynCardia

Jarvik Heart

CARMAT

AbioMed

Total Artificial Heart Segment by Type

SynCardia

Others

Total Artificial Heart Segment by Application

Dilated Cardiomyopathy

Ischemic Cardiomyopathy

Others

Total Artificial Heart Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Artificial Heart market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Total Artificial Heart and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Artificial Heart.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Total Artificial Heart market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Total Artificial Heart Industry Trends Table 2. Total Artificial Heart Industry Drivers Table 3. Total Artificial Heart Industry Opportunities and Challenges Table 4. Total Artificial Heart Industry Restraints Table 5. Global Total Artificial Heart Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Total Artificial Heart Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Total Artificial Heart Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Total Artificial Heart Sales Market Share by Manufacturers Table 9. Global Total Artificial Heart Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Total Artificial Heart Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Total Artificial Heart Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Total Artificial Heart Manufacturers, Product Type & Application Table 13. Global Total Artificial Heart Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Total Artificial Heart by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of SynCardia Table 17. Major Manufacturers of Others Table 18. Global Total Artificial Heart Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Total Artificial Heart Sales by Type (2021-2026) & (Units) Table 20. Global Total Artificial Heart Sales by Type (2027-2032) & (Units) Table 21. Global Total Artificial Heart Sales Market Share by Type (2021-2026) Table 22. Global Total Artificial Heart Sales Market Share by Type (2027-2032) Table 23. Global Total Artificial Heart Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Total Artificial Heart Revenue by Type (2021-2026) & (Units) Table 25. Global Total Artificial Heart Revenue by Type (2027-2032) & (Units) Table 26. Global Total Artificial Heart Revenue Market Share by Type (2021-2026) Table 27. Global Total Artificial Heart Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Dilated Cardiomyopathy Table 29. Major Manufacturers of Ischemic Cardiomyopathy Table 30. Major Manufacturers of Others Table 31. Global Total Artificial Heart Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Total Artificial Heart Sales by Application (2021-2026) & (Units) Table 33. Global Total Artificial Heart Sales by Application (2027-2032) & (Units) Table 34. Global Total Artificial Heart Sales Market Share by Application (2021-2026) Table 35. Global Total Artificial Heart Sales Market Share by Application (2027-2032) Table 36. Global Total Artificial Heart Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Total Artificial Heart Revenue by Application (2021-2026) & (Units) Table 38. Global Total Artificial Heart Revenue by Application (2027-2032) & (Units) Table 39. Global Total Artificial Heart Revenue Market Share by Application (2021-2026) Table 40. Global Total Artificial Heart Revenue Market Share by Application (2027-2032) Table 41. Global Total Artificial Heart Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Total Artificial Heart Sales by Region (2021-2026) & (Units) Table 43. Global Total Artificial Heart Sales Market Share by Region (2021-2026) Table 44. Global Total Artificial Heart Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Total Artificial Heart Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Total Artificial Heart Sales by Country (2021-2026) & (Units) Table 48. North America Total Artificial Heart Sales by Country (2027-2032) & (Units) Table 49. Europe Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Total Artificial Heart Sales by Country (2021-2026) & (Units) Table 51. Europe Total Artificial Heart Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Total Artificial Heart Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Total Artificial Heart Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Total Artificial Heart Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Total Artificial Heart Sales by Country (2027-2032) & (Units) Table 58. Global Total Artificial Heart Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Total Artificial Heart Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Total Artificial Heart Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Total Artificial Heart Revenue Market Share by Region (2021-2026) Table 62. Global Total Artificial Heart Revenue Market Share by Region (2027-2032) Table 63. BiVACOR Company Information Table 64. BiVACOR Business Overview Table 65. BiVACOR Total Artificial Heart Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. BiVACOR Total Artificial Heart Product Portfolio Table 67. BiVACOR Recent Development Table 68. SynCardia Company Information Table 69. SynCardia Business Overview Table 70. SynCardia Total Artificial Heart Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. SynCardia Total Artificial Heart Product Portfolio Table 72. SynCardia Recent Development Table 73. Jarvik Heart Company Information Table 74. Jarvik Heart Business Overview Table 75. Jarvik Heart Total Artificial Heart Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jarvik Heart Total Artificial Heart Product Portfolio Table 77. Jarvik Heart Recent Development Table 78. CARMAT Company Information Table 79. CARMAT Business Overview Table 80. CARMAT Total Artificial Heart Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CARMAT Total Artificial Heart Product Portfolio Table 82. CARMAT Recent Development Table 83. AbioMed Company Information Table 84. AbioMed Business Overview Table 85. AbioMed Total Artificial Heart Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AbioMed Total Artificial Heart Product Portfolio Table 87. AbioMed Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Total Artificial Heart Distributors List Table 91. Total Artificial Heart Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Total Artificial Heart Product Image Figure 2. Global Total Artificial Heart Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Total Artificial Heart Market Size (2021-2032) & (US$ Million) Figure 4. Global Total Artificial Heart Sales (2021-2032) & (Units) Figure 5. Global Total Artificial Heart Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Total Artificial Heart Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. SynCardia Image Figure 9. Others Image Figure 10. Global Total Artificial Heart Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Total Artificial Heart Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Total Artificial Heart Sales Market Share by Type (2021-2032) Figure 13. Global Total Artificial Heart Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Total Artificial Heart Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Total Artificial Heart Revenue Market Share by Type (2021-2032) Figure 16. Dilated Cardiomyopathy Image Figure 17. Ischemic Cardiomyopathy Image Figure 18. Others Image Figure 19. Global Total Artificial Heart Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Total Artificial Heart Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Total Artificial Heart Sales Market Share by Application (2021-2032) Figure 22. Global Total Artificial Heart Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Total Artificial Heart Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Total Artificial Heart Revenue Market Share by Application (2021-2032) Figure 25. North America Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Total Artificial Heart Sales Market Share by Country (2021-2032) Figure 27. U.S. Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Total Artificial Heart Sales Market Share by Country (2021-2032) Figure 32. Germany Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Total Artificial Heart Sales Market Share by Country (2021-2032) Figure 39. China Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Total Artificial Heart Sales Market Share by Country (2021-2032) Figure 47. Brazil Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Total Artificial Heart Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Total Artificial Heart Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Total Artificial Heart Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Total Artificial Heart Revenue (2021-2032) & (US$ Million) Figure 58. North America Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Total Artificial Heart Revenue (2021-2032) & (US$ Million) Figure 60. Europe Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Total Artificial Heart Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Total Artificial Heart Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Total Artificial Heart Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Total Artificial Heart Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • SynCardia
  • Others
Applications
  • Dilated Cardiomyopathy
  • Ischemic Cardiomyopathy
  • Others
Companies covered
  • BiVACOR
  • SynCardia
  • Jarvik Heart
  • CARMAT
  • AbioMed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Total Artificial Heart Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Total Artificial Heart Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Total Artificial Heart Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Total Artificial Heart Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Total Artificial Heart Market Dynamics
  1. 2.1 Total Artificial Heart Industry Trends
  2. 2.2 Total Artificial Heart Industry Drivers
  3. 2.3 Total Artificial Heart Industry Opportunities and Challenges
  4. 2.4 Total Artificial Heart Industry Restraints
3 Total Artificial Heart Market by Manufacturers
  1. 3.1 Global Total Artificial Heart Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Total Artificial Heart Sales by Manufacturers (2021-2026)
  3. 3.3 Global Total Artificial Heart Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Total Artificial Heart Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Total Artificial Heart Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Total Artificial Heart Manufacturers, Product Type & Application
  7. 3.7 Global Total Artificial Heart Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Total Artificial Heart Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Total Artificial Heart Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Total Artificial Heart Tier 1, Tier 2, and Tier 3
4 Total Artificial Heart Market by Type
  1. 4.1 Total Artificial Heart Type Introduction
  2. 4.1.1 SynCardia
  3. 4.1.2 Others
  4. 4.2 Global Total Artificial Heart Sales by Type
  5. 4.2.1 Global Total Artificial Heart Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Total Artificial Heart Sales by Type (2021-2032)
  7. 4.2.3 Global Total Artificial Heart Sales Market Share by Type (2021-2032)
  8. 4.3 Global Total Artificial Heart Revenue by Type
  9. 4.3.1 Global Total Artificial Heart Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Total Artificial Heart Revenue by Type (2021-2032)
  11. 4.3.3 Global Total Artificial Heart Revenue Market Share by Type (2021-2032)
5 Total Artificial Heart Market by Application
  1. 5.1 Total Artificial Heart Application Introduction
  2. 5.1.1 Dilated Cardiomyopathy
  3. 5.1.2 Ischemic Cardiomyopathy
  4. 5.1.3 Others
  5. 5.2 Global Total Artificial Heart Sales by Application
  6. 5.2.1 Global Total Artificial Heart Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Total Artificial Heart Sales by Application (2021-2032)
  8. 5.2.3 Global Total Artificial Heart Sales Market Share by Application (2021-2032)
  9. 5.3 Global Total Artificial Heart Revenue by Application
  10. 5.3.1 Global Total Artificial Heart Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Total Artificial Heart Revenue by Application (2021-2032)
  12. 5.3.3 Global Total Artificial Heart Revenue Market Share by Application (2021-2032)
6 Global Total Artificial Heart Sales by Region
  1. 6.1 Global Total Artificial Heart Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Total Artificial Heart Sales by Region (2021-2032)
  3. 6.2.1 Global Total Artificial Heart Sales by Region (2021-2026)
  4. 6.2.2 Global Total Artificial Heart Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Total Artificial Heart Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Total Artificial Heart Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Total Artificial Heart Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Total Artificial Heart Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Total Artificial Heart Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Total Artificial Heart Revenue by Region
  1. 7.1 Global Total Artificial Heart Revenue by Region
  2. 7.1.1 Global Total Artificial Heart Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Total Artificial Heart Revenue by Region (2021-2026)
  4. 7.1.3 Global Total Artificial Heart Revenue by Region (2027-2032)
  5. 7.1.4 Global Total Artificial Heart Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Total Artificial Heart Revenue (2021-2032)
  8. 7.2.2 North America Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Total Artificial Heart Revenue (2021-2032)
  11. 7.3.2 Europe Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Total Artificial Heart Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Total Artificial Heart Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Total Artificial Heart Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BiVACOR
  2. 8.1.1 BiVACOR Company Information
  3. 8.1.2 BiVACOR Business Overview
  4. 8.1.3 BiVACOR Total Artificial Heart Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BiVACOR Total Artificial Heart Product Portfolio
  6. 8.1.5 BiVACOR Recent Developments
  7. 8.2 SynCardia
  8. 8.2.1 SynCardia Company Information
  9. 8.2.2 SynCardia Business Overview
  10. 8.2.3 SynCardia Total Artificial Heart Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SynCardia Total Artificial Heart Product Portfolio
  12. 8.2.5 SynCardia Recent Developments
  13. 8.3 Jarvik Heart
  14. 8.3.1 Jarvik Heart Company Information
  15. 8.3.2 Jarvik Heart Business Overview
  16. 8.3.3 Jarvik Heart Total Artificial Heart Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jarvik Heart Total Artificial Heart Product Portfolio
  18. 8.3.5 Jarvik Heart Recent Developments
  19. 8.4 CARMAT
  20. 8.4.1 CARMAT Company Information
  21. 8.4.2 CARMAT Business Overview
  22. 8.4.3 CARMAT Total Artificial Heart Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CARMAT Total Artificial Heart Product Portfolio
  24. 8.4.5 CARMAT Recent Developments
  25. 8.5 AbioMed
  26. 8.5.1 AbioMed Company Information
  27. 8.5.2 AbioMed Business Overview
  28. 8.5.3 AbioMed Total Artificial Heart Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AbioMed Total Artificial Heart Product Portfolio
  30. 8.5.5 AbioMed Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Total Artificial Heart Value Chain Analysis
  2. 9.1.1 Total Artificial Heart Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Total Artificial Heart Production Mode & Process
  6. 9.2 Total Artificial Heart Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Total Artificial Heart Distributors
  9. 9.2.3 Total Artificial Heart Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst